ENTX - Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement - Click For Release
ENTX - Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement - Click For Release
Story updates
12:50:43 PM UTC
SquawkNews
ENTX Entera Bio Announces Pricing of Oversubscribed $275M Private Placement The offering is led by existing investor BVF Partners L.P. Expected gross proceeds are anticipated to extend the Company's cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first oral PTH(1-34) peptide tablet in development for the treatment of osteoporosis
12:59:40 PM UTC
SquawkNews
Entera Bio prices $275M private placement
ENTX Entera Bio Announces Pricing of Oversubscribed $275M Private Placement The offering is led by existing investor BVF Partners L.P.
Expected gross proceeds are anticipated to extend the Company's cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first oral PTH(1-34) peptide tablet in development for the treatment of osteoporosis